Aurisco Pharmaceutical Co.,Ltd.

The company was founded in 1998, focusing on R&D, production and sales of complex APIs and CRO/CDMO of oligonucleic acid drugs. It is an international pharmaceutical enterprise that continues to innovate. The company is registered in Taizhou, Zhejiang, with its operating center in Shanghai and branch companies in Yangzhou, Tianjin and Hangzhou. The company is mainly engaged in R&D, production and sales of specialty complex APIs and pharmaceutical intermediates. It is a pharmaceutical enterprise integrating scientific research, production and sales. The company's main products are raw materials and intermediates for respiratory, cardiovascular, anti-infective, neurological, anti-tumor, and women's health drugs.